EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing oxime reactivation efficacy using principal component analysis: Insights from nerve agents inhibited human butyrylcholinesterase

Goran Šinko iD, Tena Čadež iD, Zrinka Kovarik iD, Nikolina Maček Hrvat iD

ADMET and DMPK · 28.05.2026 · 14

DOI: 10.5599/admet.3361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ADMET and DMPK, online erschienen am 28.05.2026. Verfasst von Goran Šinko und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Toxicology, Institute for Medical Research and Occupational Health, Ksaverska cesta 2, HR-10000, Zagreb, Croatia. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hrvatska Zaklada za Znanost, European Regional Development Fund, NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose: The toxicity of organophosphorus compounds (OPs) and related nerve agents (NAs) impairs the cholinergic system via irreversible inhibition of acetylcholinesterase (AChE) activity by phosphylation of the catalytic serine. Reactivation of the enzyme activity largely depends on the structural compatibility between the enzyme, an oxime reactivator, and the specific OP compound. Experi­mental approach: For this study, we used our recently published data on the reactivation of human butyryl­choli­nesterase inhibited by the NAs sarin, cyclosarin, tabun and VX, using a library of 115 oximes. We compared these results with oximes’ ADME (absorption, distribution, metabolism, and excretion) parameters relevant to central nervous system activity using principal component analysis (PCA). PCA facilitated the examination of these relatively large datasets by increasing interpretability while minimizing information loss. Key results: Three components with eigenvalues above 1 resulted in 72 % of the cumulative proportion of variance and described 27 variables. PC1 created transformed data that had negative values for most oximes with high reactivation potential, while showing large positive values for oximes with moderate and low efficacy. Distribution of 27 loadings, representing 27 variables, produced a set of 9 positive and 18 negative loadings representing negative and positive data correlation. The efficacy of oxime reactivation was highly correlated with the parameters describing its structure: molecular weight, rotational bonds, molecular volume, and molecular surface area. Conclusion: A large dataset was efficiently analysed by maximizing the preservation of variability and generating new, uncorrelated variables. To our knowledge, this study is the first to apply PCA to assess oxime’s reactivation efficacy, thus providing insights into the relationships between oxime properties and their efficacy in restoring OP-inhibited cholinesterase activity.

Schlagwörter

Stichwörter der Autor:innen

ADMECholinesteraseasoxime (HI-6)organophosphatepesticidepralidoxime (2-PAM)

Autor:innen und Institutionen

  • Division of Toxicology, Institute for Medical Research and Occupational Health, Ksaverska cesta 2, HR-10000, Zagreb, Croatia.
  • University of Zagreb, Faculty of Science, Horvatovac 102, HR-10000, Zagreb, Croatia.

ORCID-Profile: Goran Šinko, Tena Čadež, Zrinka Kovarik, Nikolina Maček Hrvat

Förderung

  • Hrvatska Zaklada za Znanost
  • European Regional Development Fund
  • NextGenerationEU

Zitieren

APA

Šinko, G., Čadež, T., Kovarik, Z., & Hrvat, N. M. (2026). Assessing oxime reactivation efficacy using principal component analysis: Insights from nerve agents inhibited human butyrylcholinesterase. ADMET and DMPK, 14. https://doi.org/10.5599/admet.3361

Vancouver

Šinko G, Čadež T, Kovarik Z, Hrvat NM. Assessing oxime reactivation efficacy using principal component analysis: Insights from nerve agents inhibited human butyrylcholinesterase. ADMET and DMPK. 2026;14. doi:10.5599/admet.3361

BibTeX
@article{inko2026,
  author = {Šinko, Goran and Čadež, Tena and Kovarik, Zrinka and Hrvat, Nikolina Maček},
  title = {Assessing oxime reactivation efficacy using principal component analysis: Insights from nerve agents inhibited human butyrylcholinesterase},
  journal = {ADMET and DMPK},
  year = {2026},
  volume = {14},
  doi = {10.5599/admet.3361}
}
Kostenlos starten →